Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
SynopsisP

Uranium in drinking water, naturally

Erica Weir
CMAJ March 16, 2004 170 (6) 951-952; DOI: https://doi.org/10.1503/cmaj.1040214
Erica Weir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Background: Uranium is a naturally occurring radionuclide in granite and other mineral deposits. It enters local water, air and food supplies in varying concentrations through leaching from natural deposits, its release in mill tailings, emissions from nuclear industry, dissolution in phosphate fertilizers and combustion of coal and other fuels. The average total daily uranium intake by a 70-kg adult in Canada is estimated to be 2.6 μg, food accounting for 77% (2.0 μg) and water for most of the remainder.1 However, great regional variation in exposure levels has been reported. Uranium levels in samples of Canadian drinking water have ranged from nondetectable in certain treated municipal water samples to exceptionally high (> 700 μg/L) in some private groundwater supplies.1

Natural uranium consists almost entirely of the uranium 238 isotope in its hexavalent state, which commonly associates with oxygen as the uranyl ion UO22+. It decays by both alpha (i.e., nucleus of a helium atom) and gamma (i.e., high-energy photon) emissions. Relative to other radionuclides, natural uranium has a low level of radioactivity because of its extremely long half-life (4.5 billion years).

Although there is a risk of radiological toxicity from orally ingested natural uranium, the principal health effects are chemical toxicity. Uranyl compounds have a high affinity for phosphate, carboxyl and hydroxyl groups and readily combine with proteins and nucleotides to form stable complexes. The skeleton and kidney are the primary sites of uranium accumulation; little is found in the liver.1

On average, 1%–2% of ingested uranium is absorbed in the gastrointestinal tract in adults. The absorbed uranium rapidly enters the bloodstream and forms a diffusible ionic uranyl hydrogen carbonate complex (UO2HCO3+) in equilibrium with a nondiffusible uranyl albumin complex. In the skeleton the uranyl ion replaces calcium in the hydroxyapatite complex of the bone crystal. Once equilibrium is attained in the skeleton, uranium is excreted in urine and feces. Under alkaline conditions, the uranyl hydrogen carbonate complex is stable and is excreted. When the pH drops, the complex dissociates and binds to the cellular proteins in the tubular wall. The half-life of uranium in the rat kidney is about 15 days, and considerably longer (300–5000 days) in the skeleton.1

Nephritis is the main chemically induced effect of uranium ingestion. There is some debate as to whether the segment of the nephron most at risk to injury is the proximal tubule or the glomerulus. Evidence from animal studies does not show carcinogenic effects from ingestion of uranium compounds. An associated risk of bone cancer has been inferred from the known risk due to exposure to radium 226, a radionuclide found in uranium ore, but the estimated excess risk is considered to be insignificant compared with background lifetime risk. Thus, the maximum acceptable concentration of uranium in drinking water in Canada is calculated on the basis of chemical not radiological toxicity criteria.

Clinical management: Signs of acute uranium toxicity include piloerection, significant weight loss and hemorrhages in the eyes, legs and nose. Barring a nuclear or occupational accident, a Canadian primary care physician will probably not encounter such a case in routine practice. Little information is available on the health effects of chronic exposure to environmental uranium. Human studies comparing communities with different uranium levels in their drinking water supplies have shown a trend toward elevated alkaline phosphatase levels and increased excretion of urinary β2-microglobulin in people with increasing uranium exposure.2

Uranium exposure is not high on most primary care physicians' list of causes of early kidney disease, but it should be considered by physicians who serve communities with relatively high background levels of natural uranium. By routinely taking a thorough environmental history,3 including information on the patient's source of water supply and proximity to local industry, a physician will be in a position to suspect environmental exposure as a possible cause. The local public health unit or municipality should also have information on sources of potential local exposures.

Prevention: Studies in rats indicate that the lowest observed adverse effect level for degenerative changes in the proximal tubule is 60 μg/kg body weight per day (Box 1). After factoring in uncertainty owing to intra- and interspecies variation and adjusting for additional exposure pathways and the average daily consumption of drinking water, the Federal– Provincial– Territorial Committee on Drinking Water calculated the health-based guideline value of uranium in drinking water to be 10 μg/L (Box 1). In consideration of the water treatment costs associated with achieving this level and the low health risks associated with exceeding this level minimally, the committee has recommended an interim maximum acceptable concentration of 20 μg/L. In most jurisdictions in Canada, suppliers of drinking water monitor water quality and comply with the recommended guidelines.1

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Box 1.

Erica Weir CMAJ

Footnotes

  • I thank Brian Gibson, Associate Professor in the Department of Public Health Sciences, University of Toronto, for reviewing an earlier draft of this article.

References

  1. 1.↵
    Guidelines for Canadian drinking water quality: supporting documentation — uranium. Ottawa: Federal–Provincial–Territorial Committee on Drinking Water; 2001. Available: www.hc-sc.gc.ca/hecs-sesc/water/dwgsup.htm (accessed 2004 Feb 16).
  2. 2.↵
    Zamora ML, Tracy BL, Zielinski JM, Meyerhof DP, Moss MA. Chronic ingestion of uranium in drinking water: a study of kidney bioeffects in humans. Toxicol Sci 1998; 43 (1):68-77.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Marshall L, Weir E, Abelsohn A, Sanborn M. Identifying and managing adverse environmental health effects: 1. Taking an exposure history. CMAJ 2002;166(8):1049-55.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 170 (6)
CMAJ
Vol. 170, Issue 6
16 Mar 2004
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Uranium in drinking water, naturally
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Uranium in drinking water, naturally
Erica Weir
CMAJ Mar 2004, 170 (6) 951-952; DOI: 10.1503/cmaj.1040214

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Uranium in drinking water, naturally
Erica Weir
CMAJ Mar 2004, 170 (6) 951-952; DOI: 10.1503/cmaj.1040214
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
  • A newborn requiring selective bronchial intubation
  • Does β-blocker prophylaxis improve survival after major noncardiac surgery?
Show more Synopsis

Similar Articles

Collections

  • Topics
    • Environmental issues

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire